BMI 0 3 0 3 B-bmi
less 4 8 4 8 O
than 9 13 9 13 O
18.5 14 18 14 18 B-upper_bound

Female 0 6 19 25 B-gender
subjects 7 15 26 34 O
taking 16 22 35 41 O
hormonal 23 31 42 50 B-contraception_consent
contraceptives 32 46 51 65 I-contraception_consent
or 47 49 66 68 O
hormone 50 57 69 76 B-treatment
replacement 58 69 77 88 I-treatment
therapy 70 77 89 96 I-treatment
may 78 81 97 100 O
be 82 84 101 103 O
included 85 93 104 112 O
in 94 96 113 115 O
this 97 101 116 120 O
study 102 107 121 126 O
only 108 112 127 131 O
if 113 115 132 134 O
they 116 120 135 139 O
have 121 125 140 144 O
been 126 130 145 149 O
on 131 133 150 152 O
a 134 135 153 154 O
stable 136 142 155 161 O
dose 143 147 162 166 O
for 148 151 167 170 O
at 152 154 171 173 O
least 155 160 174 179 O
3 161 162 180 181 B-lower_bound
months 163 169 182 188 I-lower_bound

Males 0 5 189 194 B-gender

Patients 0 8 195 203 O
with 9 13 204 208 O
a 14 15 209 210 O
history 16 23 211 218 O
of 24 26 219 221 O
type 27 31 222 226 B-chronic_disease
I 32 33 227 228 I-chronic_disease
or 34 36 229 231 I-chronic_disease
type 37 41 232 236 I-chronic_disease
II 42 44 237 239 I-chronic_disease
diabetes 45 53 240 248 I-chronic_disease
or 54 56 249 251 O
HbA1c 57 62 252 257 B-clinical_variable
greater 63 70 258 265 O
than 71 75 266 270 O
6.5 76 79 271 274 B-lower_bound
% 79 80 274 275 I-lower_bound

Pregnancy 0 9 276 285 B-pregnancy

Subjects 0 8 286 294 O
initiating 9 19 295 305 O
new 20 23 306 309 B-treatment
medications 24 35 310 321 I-treatment
or 36 38 322 324 O
patients 39 47 325 333 O
on 48 50 334 336 O
multiple 51 59 337 345 B-treatment
medications 60 71 346 357 I-treatment

Subjects 0 8 358 366 O
taking 9 15 367 373 O
any 16 19 374 377 O
lipid 20 25 378 383 B-treatment
modification 26 38 384 396 I-treatment
therapy 39 46 397 404 I-treatment
, 46 47 404 405 O
including 48 57 406 415 O
but 58 61 416 419 O
not 62 65 420 423 O
limited 66 73 424 431 O
to 74 76 432 434 O
statins 77 84 435 442 B-treatment
, 84 85 442 443 O
fibrates 86 94 444 452 B-treatment
and 95 98 453 456 O
bile 99 103 457 461 B-treatment
acid 104 108 462 466 I-treatment
sequestrants 109 121 467 479 I-treatment

Subjects 0 8 480 488 O
taking 9 15 489 495 O
the 16 19 496 499 O
following 20 29 500 509 O
medications 30 41 510 521 B-treatment
for 42 45 522 525 O
at 46 48 526 528 O
least 49 54 529 534 O
six 55 58 535 538 B-lower_bound
weeks 59 64 539 544 I-lower_bound
, 64 65 544 545 O
which 66 71 546 551 O
may 72 75 552 555 O
interfere 76 85 556 565 O
with 86 90 566 570 O
the 91 94 571 574 O
study 95 100 575 580 O
, 100 101 580 581 O
will 102 106 582 586 O
be 107 109 587 589 O
excluded 110 118 590 598 O
: 118 119 598 599 O
BAS 120 123 600 603 B-treatment
, 123 124 603 604 O
antibiotics 125 136 605 616 B-treatment
, 136 137 616 617 O
anticoagulants 138 152 618 632 B-treatment
, 152 153 632 633 O
anticonvulsants 154 169 634 649 B-treatment
, 169 170 649 650 O
antiarrhythmic 171 185 651 665 B-treatment
, 185 186 665 666 O
Cyclosporine 187 199 667 679 B-treatment
, 199 200 679 680 O
Mycophenolate 201 214 681 694 B-treatment
and 215 218 695 698 O
Synthroid 219 228 699 708 B-treatment
. 228 229 708 709 O
Subjects 230 238 710 718 O
with 239 243 719 723 O
chronic 244 251 724 731 B-chronic_disease
diarrhea 252 260 732 740 I-chronic_disease
, 260 261 740 741 O
gastric 262 269 742 749 B-treatment
bypass 270 276 750 756 I-treatment
or 277 279 757 759 O
lap 280 283 760 763 B-treatment
band 284 288 764 768 I-treatment
procedures 289 299 769 779 I-treatment
, 299 300 779 780 O
ostomies 301 309 781 789 B-treatment
, 309 310 789 790 O
bowel 311 316 791 796 B-chronic_disease
motility 317 325 797 805 I-chronic_disease
problems 326 334 806 814 I-chronic_disease
, 334 335 814 815 O
or 336 338 816 818 O
other 339 344 819 824 O
conditions 345 355 825 835 O
that 356 360 836 840 O
could 361 366 841 846 O
affect 367 373 847 853 O
intestinal 374 384 854 864 O
fat 385 388 865 868 O
absorption 389 399 869 879 O

Subjects 0 8 880 888 O
with 9 13 889 893 O
acute 14 19 894 899 B-chronic_disease
liver 20 25 900 905 I-chronic_disease
disease 26 33 906 913 I-chronic_disease
or 34 36 914 916 O
active 37 43 917 923 B-chronic_disease
peptic 44 50 924 930 I-chronic_disease
ulcer 51 56 931 936 I-chronic_disease
disease 57 64 937 944 I-chronic_disease

Subjects 0 8 945 953 O
with 9 13 954 958 O
elevated 14 22 959 967 B-clinical_variable
uric 23 27 968 972 I-clinical_variable
acid 28 32 973 977 I-clinical_variable
levels 33 39 978 984 I-clinical_variable
greater 40 47 985 992 O
than 48 52 993 997 O
10 53 55 998 1000 B-lower_bound
mg 56 58 1001 1003 I-lower_bound
/ 58 59 1003 1004 I-lower_bound
dL 59 61 1004 1006 I-lower_bound
or 62 64 1007 1009 O
gout 65 69 1010 1014 B-chronic_disease

Subjects 0 8 1015 1023 O
with 9 13 1024 1028 O
weight 14 20 1029 1035 B-clinical_variable
that 21 25 1036 1040 O
varies 26 32 1041 1047 O
greater 33 40 1048 1055 O
than 41 45 1056 1060 O
20 46 48 1061 1063 B-lower_bound
% 48 49 1063 1064 I-lower_bound
over 50 54 1065 1069 O
the 55 58 1070 1073 O
past 59 63 1074 1078 B-lower_bound
3 64 65 1079 1080 I-lower_bound
months 66 72 1081 1087 I-lower_bound

females 0 7 1088 1095 B-gender

who 0 3 1096 1099 O
are 4 7 1100 1103 O
at 8 10 1104 1106 O
least 11 16 1107 1112 O
18 17 19 1113 1115 B-lower_bound
years 20 25 1116 1121 I-lower_bound
of 26 28 1122 1124 O
age 29 32 1125 1128 B-age
at 33 35 1129 1131 O
time 36 40 1132 1136 O
of 41 43 1137 1139 O
enrollment 44 54 1140 1150 O

women 0 5 1151 1156 B-gender
currently 6 15 1157 1166 O
breastfeeding 16 29 1167 1180 O

